Zoetis | ZTS - Interest Expense On Debt




Zoetis reported $51M in Interest Expense on Debt for its fiscal quarter ending in December of 2024.

Interest Expense On Debt Change Date
AbbVie USD 610M 19M Dec/2024
Bayer 642M 589.2M Sep/2024
Bristol-Myers Squibb USD 496M 9M Dec/2024
Charles River Laboratories USD 28.23M 2.05M Dec/2024
Dentsply International USD 18M 1000K Sep/2024
Eli Lilly USD 180.4M 35.5M Dec/2024
Henry Schein USD 34M 2M Sep/2024
Idexx Laboratories USD 5.3M 320K Dec/2024
Illumina USD 36M 16M Sep/2024
IQVIA Holdings USD 171M 1000K Dec/2024
J&J USD 193M 77M Sep/2024
Laboratory Of America USD 63.4M 13M Dec/2024
Merck USD 330M 20M Sep/2024
Neogen USD 17.37M 252K Nov/2024
Pacira USD 4.69M 810K Sep/2024
Patterson Companies USD 11.8M 722K Oct/2024
Perrigo 42.9M 1.2M Sep/2024
Pfizer USD 739M 45M Dec/2024
Quest Diagnostics USD 65M 16M Dec/2024
Sanofi 62M 17M Dec/2024
Sanofi 86.78M 271.68M Sep/2024
Zoetis USD 51M 6M Dec/2024